Avon Lifesciences informs about conversion of warrants into equity

28 Nov 2015

Avon Lifesciences has informed that as per the terms of 10,500,000 Warrants issued by the Company on August 12, 2015 on preferential basis, the Allotment Committee of the Board of Directors of the Company at the meeting held on November 27, 2015, has upon receipt of balance of 75% consideration aggregating to Rs.1,950,000 has approved allotment of 100,000 Equity Shares upon conversion of equivalent number of warrants at an issue price of Rs. 26 per share.

The above information is a part of company’s filings submitted to BSE.

Related Avon Lifesciences Ltd. Links:

Avon Lifescien Share Price

3.29 0.00 (0.00%) Jan 22, 18:01
1 Year Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 452.65
Lupin 747.00
Dr. Reddys Lab 3188.80
Piramal Enterprises 1679.85
Cadila Healthcare 272.15
View more..
Sensex vs Avon Lifescien
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323
Research Analyst - INH000000719

Callback

8055769463

8055769463